On Monday 12th of November, in collaboration with Immunocluster 2 project funded under Italia Slovenia Interreg Programme, project partners had an important and productive meeting with the Slovenian JAZMP (Agency for Medicinal Products and Medical Devices of the Republic of Slovenia). This meeting marks a pivotal step forward in our efforts to enhance cross-border healthcare initiatives between Italy and Slovenia.
Highlights of our progress:
Regulatory advancement: Our discussion with JAZMP is paving the way for smoother regulatory processes in upcoming clinical trials.
Advancing the therapy: With promising pre-clinical data, we are moving from the laboratory towards clinical studies. Today meeting has been a milestone in clarifying the regulatory framework that will bring us close to patients for improved care.
Future Steps:
Preparing our CAT application.
Continuing close collaboration with all stakeholders.
Advancing towards innovative healthcare solutions.
Read more on the following link.
